SW
NVAX icon

SVB Wealth’s Novavax NVAX Stock Holding History

SVB Wealth’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,000
Closed -$25K – 505
2016
Q4 		$25K Hold
1,000
– – ﹤0.01% 482
2016
Q3 		$42K Hold
1,000
– – ﹤0.01% 508
2016
Q2 		$145K Hold
1,000
– – 0.01% 494
2016
Q1 		$103K Buy
1,000
+500
+100% +$53.6K ﹤0.01% 502
2015
Q4 		$84K Buy
+500
New +$76.9K ﹤0.01% 522
2015
Q1 		– Sell
-750
Closed -$89K – 562
2014
Q4 		$89K Buy
+750
New +$78.4K ﹤0.01% 529

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SVB Wealth's NVAX Position: Q1 2017 in Review

SVB Wealth sold out of Novavax (NVAX) in Q1 2017, closing a stake of 1,000 shares — an estimated $25K sold.

SVB Wealth first reported a position in NVAX in Q4 2014 and held it in 6 quarters. The position peaked at $145K in Q2 2016. 130 funds tracked by Wall St. Rank hold NVAX as of Q1 2017.

  • SVB Wealth reported no remaining Novavax position as of Q1 2017 after selling out during the quarter.
  • SVB Wealth sold 1,000 Novavax shares in Q1 2017, an estimated $25K.
  • SVB Wealth first reported a position in Novavax in Q4 2014 and held it in 6 quarters.
  • SVB Wealth's Novavax position peaked at $145K in Q2 2016.
  • 130 funds tracked by Wall St. Rank held Novavax as of Q1 2017.

Based on SVB Wealth's 13F filing for Q1 2017, filed 11 May 2017.